These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8809404)

  • 1. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations.
    Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT
    Cell Growth Differ; 1996 Jul; 7(7):871-8. PubMed ID: 8809404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3' untranslated region of prohibitin and cellular immortalization.
    Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT
    Exp Cell Res; 1996 Apr; 224(1):128-35. PubMed ID: 8612677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer.
    Manjeshwar S; Branam DE; Lerner MR; Brackett DJ; Jupe ER
    Cancer Res; 2003 Sep; 63(17):5251-6. PubMed ID: 14500355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines.
    Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT
    Exp Cell Res; 1995 Jun; 218(2):577-80. PubMed ID: 7796893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of prohibitin gene mutations in human epithelial ovarian tumors.
    Cliby W; Sarkar G; Ritland SR; Hartmann L; Podratz KC; Jenkins RB
    Gynecol Oncol; 1993 Jul; 50(1):34-7. PubMed ID: 8349162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved CPEs in the p53 3' untranslated region influence mRNA stability and protein synthesis.
    Rosenstierne MW; Vinther J; Mittler G; Larsen L; Mann M; Norrild B
    Anticancer Res; 2008; 28(5A):2553-9. PubMed ID: 19035278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.
    Plummer SJ; Adams L; Simmons JA; Casey G
    Oncogene; 1997 May; 14(19):2339-45. PubMed ID: 9178910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
    Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.